论文信息 - Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma - 字舞流文

Phase II trial of uracil/tegafur (UFT) plus leucovorin in patients with advanced hepatocellular carcinoma

E. Vokes | T. Schiano | S. Mani | B. Samuels | S. Benner | R. Ansari | D. Sciortino | K. Shulman | Juan C. Garcia | A. Baker | S. Tembe

[1] S. Mani. UFT plus leucovorin in advanced hepatobiliary tumors and pancreatic adenocarcinomas. , 1997, Oncology.

[2] R. Pazdur. Phase I and pharmacokinetic evaluations of UFT plus oral leucovorin. , 1997, Oncology.

[3] Y. Maehara,et al. Scientific basis for the combination of tegafur with uracil. , 1997, Oncology.

[4] T. Taguchi. Experience with UFT in Japan. , 1997, Oncology.

[5] A. Venook. Treatment of hepatocellular carcinoma: too many options? , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6] T. Taguchi,et al. [Report on nationwide pooled data and cohort investigation in UFT phase II study]. , 1987, Gan to kagaku ryoho. Cancer & chemotherapy.